Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Avacopan may cause unexpected side effects, so early monitoring is important.

Baricitinib effectively improves symptoms of atopic dermatitis and alopecia areata with few side effects.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Current treatments for severe alopecia areata in children are often ineffective, with frequent relapses and long treatment durations.

Generic Palbociclib is safe and tolerable for treating certain breast cancer types.

Including special area involvement helps identify more psoriasis patients who may need systemic treatment.

Ritlecitinib is effective and safe for treating alopecia areata, especially in newer cases.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Dutasteride is cheaper than finasteride for treating benign prostatic hyperplasia.

EGFR-TKIs can cause unexpected skin, nail, and hair issues.

Sacituzumab govitecan is effective but has side effects like hair loss and diarrhea in treating metastatic triple-negative breast cancer.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

Adolescents with severe alopecia incur significantly higher healthcare costs.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Many drugs can cause lipid metabolism issues, and labels need better warnings.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

Most dermatology drugs in Denmark are used correctly, with few unusual patterns.

Certain drugs can cause eyelid inflammation, so doctors should monitor and educate patients on eyelid care.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

GLP-1RA therapy may increase the risk of hair loss.

Baricitinib effectively reduces hair loss in severe alopecia areata and is generally safe.

Alopecia areata in Spain has a significant impact with unmet treatment needs and high costs.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

The study aims to understand how mood, physical activity, light exposure, and seasonal changes affect sleep patterns.

The representation of skin conditions in medical reviews partly matches their real-world impact.

Deucravacitinib effectively treats psoriasis and may help with other skin conditions.

An AI device for skin cancer was successfully integrated into the NHS, improving diagnosis accuracy and service capacity.

Large language models struggle with accurate clinical decision-making compared to real-world needs.

The TPAP method effectively categorizes androgenetic alopecia patients with high accuracy, but needs real-world validation.